Chia Tai Enterprises International Ltd (HKSE:03839) Share Price

Company Profile

Business description
Chia Tai Enterprises International Ltd is engaged in the manufacture and sale of chlortetracycline (CTC) and animal health products. The company's operating segments include Biochemical operations and Industrial operations. It generates maximum revenue from the Biochemical operations segment, which is engaged in the manufacture and sale of chlortetracycline and animal health products. The Industrial segment is into the trading of machinery and the manufacture and sale of automotive parts through the group's joint ventures and associates. Its geographical segments are Mainland China, which generates key revenue, Asia Pacific (excluding mainland China), the Americas, Europe, and Others.
Contact
16 Harcourt Road
21st Floor, Far East Finance Centre
Hong Kong
HKG
T: +852 25201601
http://www.ctei.com.hk
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2025
Employees
900

Recommended

These undervalued stocks with wide and narrow moats have increased their dividends for 25 consecutive years or more.

Susan Dziubinski | 30 July 2025

We raise our Fair Value estimates but still think that current share prices rely on overly optimistic expectations.

Shaun Ler | 30 July 2025

With a diverse portfolio of innovative technology and integrated media platforms, here’s what we think of Alphabet’s stock.

Malik Ahmed Khan, CFA | 30 July 2025

Index	Last price	Change	% Change
All Ordinaries	8,995.80	19.60	-0.22%
CAC 40	7,861.96	4.60	0.06%
DAX 40	24,262.22	44.85	0.19%
Dow JONES (US)	44,461.28	171.71	-0.38%
FTSE 100	9,136.94	0.62	0.01%
HKSE	24,799.91	377.02	-1.50%
NASDAQ	21,129.67	31.38	0.15%
Nikkei 225	41,102.12	447.42	1.10%
NZX 50 Index	12,823.74	32.23	-0.25%
S&P 500	6,362.90	7.96	-0.12%
S&P/ASX 200	8,740.20	16.20	-0.19%
SSE Composite Index	3,580.98	34.73	-0.96%